"Taiwan Pharmaceuticals & Healthcare Report Q2 2011" now available at Fast Market Research

Recently published research from Business Monitor International, "Taiwan Pharmaceuticals & Healthcare Report Q2 2011", is now available at Fast Market Research
 
March 19, 2011 - PRLog -- Taiwan's pharmaceutical market is calculated to have reached a value of around TWD129bn (US$4.10bn) in 2010. Through to 2015 and 2020, respectively, BMI is forecasting local currency compound annual growth rates (CAGRs) of 3.89% and 4.09% respectively for combined sales of prescription drugs and over-the-counter (OTC) medicines. As the Taiwanese dollar strengthens, CAGRs expressed in US dollars will be higher, at 4.90% and 4.60%, respectively. However, the market is relatively mature, and - as the government foots over 60% of the total healthcare spend - downward pressures on pharmaceutical prices can be expected, while inflation also remains subdued. In the meantime, the OTC sub-sector will remain underdeveloped, due to relatively generous reimbursement.

The above outlook explains why Taiwan is a moderately attractive pharmaceutical market in Asia Pacific. In our proprietary Pharmaceuticals & Healthcare Business Environment Ratings (BER), the country again ranks 7th out of the 17 countries surveyed regionally. Even though Taiwan has a relatively favourable operational risk profile, over the medium term, we expect the country to slip down the ranking system, due to improvements in the reward profile of nascent markets. While market access in Taiwan is comparatively straightforward, pricing pressures will continue to increase, especially as patented drugs account for nearly two thirds of Taiwan's pharmaceutical market in terms of sales values.

However, budgetary constraints are leading the authorities to make more prudent reimbursement decisions. In fact, in early 2011, Taiwan quashed rumours relating to access to free cocktail therapy for AIDS patients. The government will not totally scrap the policy, but the health department plans to make modifications in 2011, including passing some financial responsibility for the treatment onto the majority of the patients, with more vulnerable groups to be exempt from charges. Similarly, more affluent citizens will be required to pay extra in insurance premiums.

In the meantime, the healthcare industry in Taiwan is reaching saturation point and suffering from a downturn. This is evident from declining profit margins, the closure of hospitals, the oversupply of medical professionals and various economic indexes, the Liberty Times reported. The Department of Health has suggested that the decline of the healthcare industry could be halted with the development of the health tourism industry, targeting the international and Chinese markets. Many Taiwan-based enterprises are already looking to develop collaborations with Chinese companies to serve the latter's growing medical market. Nevertheless, Taiwan is expected to post 4.3% real GDP growth in 2011, on the back of both solid domestic economic momentum and a stronger growth outlook for both China and the US, which should provide a foundation for the steady development of its pharmaceutical market, downplaying the severity of government cost-cutting policies.

For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/127268_taiwan_pharmaceuticals_...


Partial Table of Contents:

SWOT Analysis
- Taiwan Pharmaceuticals And Healthcare Industry SWOT
- Taiwan Political SWOT
- Taiwan Economic SWOT
- Taiwan Business Environment SWOT
Pharmaceutical Business Environment Ratings
- Table: Asia Pacific - Regional Pharmaceutical Business Environment Ratings, Q211
- Rewards
- Risks
Taiwan - Market Summary
Regulatory Regime
- Table: Examples Of Controlled Drugs In Taiwan
- Table: Medicine Categories In Taiwan
- Recent Regulatory Developments
- Intellectual Property Regime
- Intellectual Property Developments
- Compulsory Licensing
- Counterfeits
- Pricing Regime
- Price Cuts
- Reimbursement Regime
- Table: BNHI Spending by Type of Outpatient Claims, as Percentage of Total
- Table: Drug Reimbursement Principles
- Free Trade Agreements
Industry Developments
- Epidemiology
- Non-Communicable Diseases
- Communicable Diseases
- Healthcare System
- Healthcare Insurance
- Healthcare Financing
- Taiwan: Insurance Coverage
- Recent Healthcare System Developments
- Traditional Chinese Medicine
- Biotechnology Sector
- Recent Biotechnology Developments
- Clinical Trials
- Medical Tourism
- Vaccines
- Recent Developments In The Vaccines Market
- Medical Devices
Industry Forecast Scenario
- Table: Pharmaceutical Sales Indicators 2007-2015
- Key Growth Factors - Industry
- Table: Health Expenditure Indicators 2007-2015
- Table: Government Health Expenditure Indicators 2007-2015
- Table: Private Health Expenditure Indicators 2007-2015
- Key Growth Factors - Macroeconomic
- Table: Taiwan - Economic Activity
- Prescription Drug Market Forecast
- Table: Prescription Drug Sales Indicators 2007-2015
- Patented Drug Market Forecast
- Table: Patented Drug Sales Indicators 2007-2015
- Generic Drug Market Forecast
- Table: Generic Drug Sales Indicators 2007-2015
- OTC Medicine Market Forecast
- Table: OTC Medicine Sales Indicators 2007- 2015
- Medical Device Market Forecast
- Table: Medical Device Sales Indicators 2007-2015
- Pharmaceutical Trade Forecast
- Table: Pharmaceutical Imports & Exports Indicators 2007-2015
- Other Healthcare Data Forecasts
-

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=1272...

About Business Monitor International

Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets.  BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports.  Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports.  View more research from Business Monitor International at http://www.fastmr.com/catalog/publishers.aspx?pubid=1010

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
End
Source: » Follow
Email:***@fastmr.com Email Verified
Zip:01267
Tags:Pharmaceutical, Healthcare, Health, Department, Meantime, Patients, Dollar, Otc, Medical, Drugs
Industry:Health, Medical, Research
Location:Massachusetts - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Fast Market Research PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share